Abstract
Kidney stone disease is a highly prevalent condition associated with substantial health care cost and patient morbidity. After an initial stone event, the recurrence rate of nephrolithiasis is estimated to be between 35% and 50%. 1 Uribarri J. Oh M.S. Carroll H.J. The first kidney stone. Ann Intern Med. 1989; 111: 1006-1009 Crossref PubMed Scopus (268) Google Scholar The total annual medical expenditures for urolithiasis in the United States were approximately $2.1 billion in 2000. 2 Lotan Y. Economics and cost of care of stone disease. Adv Chronic Kidney Dis. 2009; 16: 5-10 Abstract Full Text Full Text PDF PubMed Scopus (113) Google Scholar One area of potential reduction in morbidity and health care cost is prevention of recurrent nephrolithiasis. Patient-centered Medical Therapy for NephrolithiasisUrologyVol. 81Issue 3PreviewTo elucidate the effect of a patient-centered combined nutritional and medical therapy approach on stone disease management, guided by 24-hour urinary stone risk. Full-Text PDF
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
